16th Mar 2007 17:31
Oxford Biomedica PLC16 March 2007 Oxford BioMedica plc ("the Company") Holdings in Company Further to the announcement of the completion of the acquisition of OxxonTherapeutics Limited ("Oxxon") on 15 March 2007, the Company announces that, ofthe 27,551,628 ordinary shares of 1p each in the Company ("Ordinary Shares")issued as consideration for the acquisition, 1,737,490 Ordinary Shares, thatwere not subject to a lock up, have been placed with existing institutionalinvestors. Following this sale, Oxxon Therapeutics Holdings, Inc. (the historic holdingcompany of Oxxon) is interested in 25,814,138 Ordinary Shares, representing 4.84per cent. of the Company's issued share capital, all of which are subject to alock up agreement for six months from the date of the acquisition, followed by aperiod of orderly disposal through Evolution Securities Limited, the Company'scorporate broker. 16 March 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica